As of May 27
| +0.085 / +0.92%|
The 4 analysts offering 12-month price forecasts for Rockwell Medical Inc have a median target of 5.50, with a high estimate of 9.00 and a low estimate of 3.00. The median estimate represents a -41.18% decrease from the last price of 9.35.
The current consensus among 5 polled investment analysts is to Hold stock in Rockwell Medical Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.